FDA warns firms selling unapproved narcotics (Reuters)

Reuters – U.S. regulators warned nine companies on Tuesday to stop selling 14 unapproved narcotic pain medicines, part of an ongoing effort to rid the market of drugs without proper clearance.

Comments are closed.